We manufacture all our biosimilars in Iceland, a country which imports more goods from the U.S. than it exports to the U.S., ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results ...

Zealand Pharma A/S (ZLDPF) shares ended the last trading session 8% higher at $72.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Lauren Spencer Smith is set to embark on a thrilling world tour in celebration of her highly anticipated second album, The Art of Being a Mess. The Canadian-born artist, known for her heartfelt lyrics ...

Douglas Pharmaceuticals, New Zealand’s largest privately owned pharmaceutical company, announces the launch of Winlevi® ...

Zealand Pharma A/S advanced stock charts by Barron's. View ZLDPF historical stock data and compare to other stocks, and exchanges.

Copenhagen, Denmark Saturday, April 26, 2025, 18:00 Hrs [IST] ...

Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...

Fresh off a splashy obe­si­ty deal, Zealand Phar­ma is dou­bling down on its R&D am­bi­tions with a new chief sci­en­tif­ic of­fi­cer.

Utpal joins Zealand Pharma at a pivotal moment as it aims to become a leader in the management of obesity and related complications He will lead the discovery and clinical translation of peptide ...